2004
DOI: 10.1016/j.transci.2003.11.006
|View full text |Cite
|
Sign up to set email alerts
|

Cord blood (CB) stem cells for wound repair Preliminary report of 2 cases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
13
0

Year Published

2007
2007
2024
2024

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 33 publications
(13 citation statements)
references
References 9 publications
0
13
0
Order By: Relevance
“…102 The third report described two patients with non-healing wounds who were treated with autologous fibrin glue containing allogeneic CB isolated CD34 þ cells. 103 Immunological properties of USSC As described by our group in cooperation with A Dickinson (Newcastle), USSC are conditionally immunosuppressive, and IFNg and TNFa constitute a switch that regulates their immunological properties. 104 They either suppress T-cell responses in the presence of both cytokines or in their absence block DC differentiation and function.…”
mentioning
confidence: 99%
“…102 The third report described two patients with non-healing wounds who were treated with autologous fibrin glue containing allogeneic CB isolated CD34 þ cells. 103 Immunological properties of USSC As described by our group in cooperation with A Dickinson (Newcastle), USSC are conditionally immunosuppressive, and IFNg and TNFa constitute a switch that regulates their immunological properties. 104 They either suppress T-cell responses in the presence of both cytokines or in their absence block DC differentiation and function.…”
mentioning
confidence: 99%
“…In a study done by Valbonessi et al, fibrin platelet glue was used as a vehicle to deliver the CD34+ve cord blood cells topically onto the wound. 8 Though the study was limited to 2 cases, it demonstrated the presence of multi-potent cells in the HUCB which could also be harvested.…”
Section: Discussionmentioning
confidence: 99%
“…There is evidence that UCB-MSCs can improve wound healing and UCB-MSCs CD34+ cells were employed to treat skin wounds refractory to conventional treatment including surgery. 43 Moreover, several clinical trials are ongoing to evaluate the application of these cells in the treatment of burns (clinicaltrials.gov NCT01443689), and chronic diabetic wounds (clinicaltrials.gov NCT01413035).…”
Section: Bone Marrow Mesenchymal Stem Cells (Bm-mscs)mentioning
confidence: 99%